<DOC>
	<DOCNO>NCT01884974</DOCNO>
	<brief_summary>Pulmonary hypertension ( PH ) define group disease characterise elevated mean pulmonary artery pressure ( Ppa ) â‰¥25 mmHg rest . Recently , chronic myeloproliferative disease ( CMPD ) associate pulmonary hypertension include group 5 category , correspond PH aetiology unclear and/or multifactorial . CMPD include chronic myelogenous leukaemia , chronic neutrophilic leukaemia chronic eosinophilic leukaemia ( primarily express myeloid phenotype polycythaemia vera ) , idiopathic myelofibrosis , essential thrombocytosis erythroid megakaryocytic hyperplasia predominates . The purpose research : 1 . Assess Prevalence PH patient CMPD Northern Israel 2 . Describe demographic clinical course patient CMPD diagnose PH .</brief_summary>
	<brief_title>A Case Control Study Prevalence Pulmonary Hypertension Patients With Myeloproliferative Diseases .</brief_title>
	<detailed_description>study include follow : - sex - age - BMI - ethnicity - age diagnose Myeloproliferative disease - clinical manifestation myeloproliferative disease - JAK2 mutation - know hematological complication</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<criteria>1 ) consenting patient diagnose myeloproliferative disease 1 ) Refusal echocardiogram answer St. George respiratory questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Myeloproliferative disease</keyword>
	<keyword>Pulmonary Hypertension</keyword>
</DOC>